NASDAQ
Enveric Biosciences, Inc. (ENVB) has a free cash flow growth of -26.44% as of Friday, May 29, 2026. This represents a 84.99% decrease compared to its 12-month average of -14.29%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.